Delivery Order SPE2DB24D2100-SPE2DB25FBESC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $37,169.95 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 10, 2025, with completion targeted for September 11, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,297.06 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on June 27, 2025, with completion scheduled for June 30, 2025. This firm fixed price, competitively awarded delivery order represents a pharmaceutical supply requirement without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,377.52 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed price, non-set-aside contract reflects a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) under a firm fixed price contract valued at $22,704.73, with an ultimate completion date of July 9, 2025. This non-set-aside delivery order represents a competitive award to the major pharmaceutical distributor, which maintains its corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 25 mg tablets (90-count packaging) with a ceiling value of $86,831.47. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, represents a competitive award with no set-aside designation. The contract is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $1,571.08. This contract represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The award was made through open competition with no set-aside designation. Performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,540.20 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBESCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,670.24 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on June 12, 2025, with a completion date of June 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through the DLA Medical Supply Chain. The company's IDC vehicle enables the delivery of a broad range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and specialty medical commodities across multiple therapeutic domains—to support military healthcare programs globally. This specific delivery order for Jardiance, a diabetes medication, represents one of numerous pharmaceutical transactions AmerisourceBergen fulfills through its federal contract portfolio, demonstrating the company's established capacity to meet Department of Defense medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.7k | 6/12/25 |